Italy Patient Support Programs (PSP) Market Analysis

Italy Patient Support Programs (PSP) Market Analysis


$ 3999$ 2999

Italy's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 9.4% for the year 2022-30. Simpler and affordable patient-centric services due to recent developments like telemedicine and support from the Italian government for patient empowerment and self-management are major market drivers for the growth of the Italy Patient Support Programs (PSP) market. The market is segmented by functionality outlook, therapeutic outlook, application outlook, and the end user. Some of the top PSP operators in the Italy Patient Support Programs (PSP) market are Domedica, Sarpharma, and Healthcare Network Partners

ID: IN10ITHS014 CATEGORY: Healthcare Services GEOGRAPHY: Italy AUTHOR: Parul Choudhary

Buy Now

Italy Patient Support Programs (PSP) Market Executive Analysis

Italy's Patient Support Programs (PSP) market size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of 9.4% during the forecast period. According to the World Health Organization (WHO), Italy is one of the top 10 countries for providing high-quality healthcare. Italian healthcare is ranked as the second-best in the world by the WHO. At 79.4 years for males and 84.8 years for women, life expectancy is comparatively high.

In Italy, the National Health System (NHS) costs that the State contributes to are determined annually by the Finance Act at a general level of resources. The National Health Fund (NHF), which will increase from $130.56 Bn to $132.70 Bn in 2022, to $134.84 Bn in 2023, and to $136.98 Bn in 2024, has received an additional $2.14 Bn over the course of the next three years according to the 2022 Finance Act. In addition to those envisioned under the National Recovery and Resilience Plan (PNRR), new funding has been committed to ensuring the execution of organizational, quantitative, qualitative, and technological standards.

Patient Support Programs (PSPs) are an umbrella term for activities sponsored by pharmaceutical corporations to promote prescription drug availability, consumption, and adherence. PSPs can be divided into three primary categories: financial help, clinical support, and support for adherence. A single PSP may include elements from each of these category types. The Novartis-funded PSP PSOLife CARE, developed and implemented by IQVIA, was intended to assist Italian psoriasis patients receiving Secukinumab medication. This PSP came at no cost to the patients or the Italian National Health Services.

The Italian Pharmaceutical Industry Association (Farmindustria) endorsed new recommendations for patient support programs on January 19, 2022. According to the new standards, patient support programs are actions taken by pharmaceutical companies with the intention of providing additional services that directly benefit patients. These services are not meant to take the place of those offered by hospitals and other healthcare facilities. Regarding the handling of patient personal data, the new regulations provide that pharmaceutical corporations must only access aggregated data for statistical analysis of the use of the services rather than directly processing the data of patients participating in patient support programs.

italy patient support program market analysis

Market Dynamics

Market Growth Drivers

Delivering patient support services has become simpler and more affordable owing to developments in digital health technology like telemedicine and remote patient monitoring. Consequently, Italy's PSP market now has more opportunities. The Italian government has promoted the creation and implementation of patient support programs by enacting a number of regulations and initiatives. To assist patient empowerment and self-management, the Ministry of Health, for example, has started a national program that involves the development of patient support programs.

Market Restraints

PSPs' advantages and their proper use may not be completely grasped by patients and healthcare professionals. The adoption of PSPs may be limited by this lack of knowledge and guidance, and patients may not benefit fully from these programs thereby limiting the Italy PSP market growth.

Major Patient Support Programs in Italy

Patient Support Programs Focus Area Pharma Sponsor
PSOLife Care Psoriasis Novartis
Hemozone Hemophilia BIOVIIIx
Clickservice Growth disorders and GH deficiency Merck
Contantinus DFU Diabetic Foot Ulcer Molteni
Trovarsi Schizophrenia Angelini
Lilfully General wellness Cheisi
Turbo+ Asthma and COPD AstraZeneca
Vinci di Salute Atrial Fibrillation, Acromegaly, Breast cancer, Rheumatoid arthritis and Ulcerative colitis Philips, Pfizer
Adveva Multiple sclerosis Merck
Sandoz One Source Neutropenia and Hematopoietic Subsyndrome Sandoz
NoiPerT (r) e Women’s Health GSK

Top PSP Operators in Italy

  1. Domedica- an IQVIA business supported clinical centers, patients, and the health ecosystem with innovative solutions and projects: Patient Support Programs (PSP); support and home delivery; emotional and psychological assistance projects; training and education; decentralized and home clinical trials
  2. Sarpharma- Sarpharma specializes in the development of medicinal products, regulatory affairs, market access, pharmacovigilance, and clinical research
  3. Healthcare Network Partners- HNP Italy Srl is the company of the HNP Group - Healthcare Network Partners, which offers assistance services to patients and Clinical Centres with the aim of guaranteeing therapeutic adherence and increasing the value for the patient
  4. Alcura- Alcura offers solutions for companies involved in the development and supply of innovative medicines, to ensure efficient management of clinical trials, market access, and valuable support to patients, so as to improve the outcomes associated with medicines and the achievement of business objectives
  5. Human AssistCare- Human AssistCare's Patient Support Programs (PSP) improve the quality of life of people suffering from rare or chronic diseases and guarantee them the adherence and effectiveness of drug therapy

Healthcare Policies and Regulatory Landscape

From a legal point of view, no specific regulation of PSPs has been developed at the European or national level, however, their existence is recognized in Europe, and to date, they have been regulated from a pharmacovigilance point of view since when a PSP is initiated in relation to specific products, it is essential to comply with pharmacovigilance regulations. PSPs must be designed and implemented by compliance and medical affairs departments in order to avoid any commercial purpose and use.

Italy's association for pharmaceutical companies has amended its Code of Ethics with 4 new articles on PSP and on the promotion of medicines. The Board of Farmindustria, the Italian Pharmaceutical Companies Association, recently approved amendments to its code of conduct that are of interest in connection with information and promotion activities. Key pointers include the provider may send its specialized, qualified, and previously trained personnel to the patient's home or to public or private health facilities, provided that the relationship between the company and the supplier falls within the form of a service contract and The duration of the services offered by the PSP must be previously defined and the corporate function that has the decision-making responsibility of the PSP must not be commercial and must operate under the supervision of the company's compliance function.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

​Italy Patient Support Programs (PSP) Market Segmentation

By Functionality Outlook

  • Communication
  • Health Tracking & Insights
  • Billing & Payments
  • Administrative
  • Patient Education
  • Others

By Therapeutic area outlook

  • Health & Wellness
  • Chronic Disease Management
  • Others

By Application outlook

  • Population Health Management
  • Outpatient Health Management
  • In-patient Health Management
  • Others

By End-user

  • Payers
  • Providers
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 17 August 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up